evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomat... by Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens

Get full text

Frequency of missed or delayed diagnosis in dementia is associated with neighborhood socioeconomic status by Ellen Holm, Katja Kemp Jacobsen, Thea Bang deLony, Maurice Lembeck, Hanne Pedersen, Charlotte Andersson, Peter Johannsen, Terese Sara Høj Jørgensen, Christian Torp‐Pedersen

Get full text

A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker d... by Daniel Stamate, Min Kim, Petroula Proitsi, Sarah Westwood, Alison Baird, Alejo Nevado‐Holgado, Abdul Hye, Isabelle Bos, Stephanie J.B. Vos, Rik Vandenberghe, Charlotte E. Teunissen, Mara Ten Kate, Philip Scheltens, Silvy Gabel, Karen Meersmans, Olivier Blin, Jill Richardson, Ellen De Roeck, Sebastiaan Engelborghs, Kristel Sleegers, Régis Bordet, Lorena Ramit, Petronella Kettunen, Magda Tsolaki, Frans Verhey, Daniel Alcolea, Alberto Lléo, Gwendoline Peyratout, Mikel Tainta, Peter Johannsen, Yvonne Freund‐Levi, Lutz Frölich, Valerija Dobricic, Giovanni B. Frisoni, José L. Molinuevo, Anders Wallin, Julius Popp, Pablo Martinez‐Lage, Lars Bertram, Kaj Blennow, Henrik Zetterberg, Johannes Streffer, Pieter J. Visser, Simon Lovestone, Cristina Legido‐Quigley

Get full text